We are live on ! Find out more
MME

Meag Munich Ergo Portfolio holdings

AUM $3.54B
1-Year Est. Return 20%
This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
+20%
3 Year Est. Return
+82.79%
5 Year Est. Return
+144.54%
10 Year Est. Return
+335.02%
AUM
$1.1B
AUM Growth
-$835M
Cap. Flow
-$836M
Cap. Flow %
-75.92%
Top 10 Hldgs %
23.85%
Holding
267
New
31
Increased
38
Reduced
46
Closed
95

Top Buys

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$24M
2
EIX icon
Edison International
EIX
+$23.2M
3
TWX
Time Warner Inc
TWX
+$23.1M
4
TSN icon
Tyson Foods
TSN
+$21.9M
5
PFE icon
Pfizer
PFE
+$20.7M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$46.1M
2
T icon
AT&T
T
+$45.1M
3
DB icon
Deutsche Bank
DB
+$42.6M
4
AAPL icon
Apple
AAPL
+$40.3M
5
MO icon
Altria Group
MO
+$36.1M

Sector Composition

Rank Sector Weight
1 Financials 17.93%
2 Healthcare 13.49%
3 Consumer Staples 11.38%
4 Industrials 11.27%
5 Real Estate 10.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DB icon
1
Deutsche Bank
DB
$69B
$47.3M 4.29%
3,885,984
-2,838,964
-42% -$42.6M
BXP icon
2
Boston Properties
BXP
$11.2B
$27.4M 2.48%
207,854
ABBV icon
3
AbbVie
ABBV
$443B
$26M 2.36%
424,466
+173,542
+69% +$10.6M
CL icon
4
Colgate-Palmolive
CL
$73.1B
$25M 2.27%
342,850
+337,250
+6,022% +$24M
EIX icon
5
Edison International
EIX
$28.2B
$24.8M 2.25%
+323,000
New +$23.2M
STZ icon
6
Constellation Brands
STZ
$22.2B
$23.2M 2.11%
140,359
+73,508
+110% +$11.5M
TWX
7
DELISTED
Time Warner Inc
TWX
$22.8M 2.07%
+312,064
New +$23.1M
TSN icon
8
Tyson Foods
TSN
$20.4B
$22.5M 2.04%
+338,096
New +$21.9M
PFE icon
9
Pfizer
PFE
$143B
$21.9M 1.99%
658,009
+649,577
+7,704% +$20.7M
CLX icon
10
Clorox
CLX
$11.6B
$21.8M 1.98%
159,045
+133,906
+533% +$17.4M
CRM icon
11
Salesforce
CRM
$151B
$21.8M 1.98%
283,027
AVB icon
12
AvalonBay Communities
AVB
$26.5B
$20.1M 1.83%
112,121
+81,621
+268% +$14.7M
SYK icon
13
Stryker
SYK
$125B
$19.7M 1.79%
165,225
+134,892
+445% +$15.1M
ACN icon
14
Accenture
ACN
$102B
$19.4M 1.76%
+171,862
New +$19.9M
GILD icon
15
Gilead Sciences
GILD
$162B
$19.2M 1.74%
230,724
-83,897
-27% -$7.45M
MSFT icon
16
Microsoft
MSFT
$3.45T
$18.9M 1.72%
371,063
-75,622
-17% -$3.93M
BNY
17
Bank of New York Mellon
BNY
$106B
$17M 1.54%
440,820
-160,068
-27% -$6.37M
RY icon
18
Royal Bank of Canada
RY
$291B
$16.9M 1.53%
284,000
TD icon
19
Toronto Dominion Bank
TD
$198B
$16.8M 1.52%
388,200
SYY icon
20
Sysco
SYY
$40.8B
$15.6M 1.42%
308,273
+208,151
+208% +$10.1M
AMGN icon
21
Amgen
AMGN
$208B
$15.6M 1.41%
102,511
+51,025
+99% +$7.93M
PPL
22
PPL Corp
PPL
$26.5B
$15.4M 1.4%
408,895
+185,835
+83% +$7.08M
VZ icon
23
Verizon
VZ
$195B
$15.2M 1.38%
271,638
-188,551
-41% -$9.78M
SWK icon
24
Stanley Black & Decker
SWK
$14.3B
$15.1M 1.37%
+136,803
New +$15.2M
UBS icon
25
UBS Group
UBS
$173B
$14.6M 1.33%
1,127,696
-698,769
-38% -$10.7M

Similar funds

Meag Munich Ergo's Q2 2016 Portfolio in Review

As of Q2 2016, Meag Munich Ergo held 267 positions worth $1.1B, down 43% from $1.94B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Meag Munich Ergo withdrew a net $836M in Q2 2016, closing 95 positions and reducing 46 holdings. Its most notable exit was Johnson & Johnson, an estimated $46.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Meag Munich Ergo opened a new position in Edison International worth $24.8M.

  • Meag Munich Ergo's largest Q2 2016 buy was Edison International: 323,000 shares worth $24.8M.
  • Meag Munich Ergo added most to Colgate-Palmolive in Q2 2016, an estimated $24M increase.
  • Meag Munich Ergo's biggest Q2 2016 reduction was Deutsche Bank, cutting an estimated $42.6M.
  • Meag Munich Ergo fully exited Johnson & Johnson in Q2 2016, selling an estimated $46.1M.
  • Meag Munich Ergo's ten largest holdings make up 24% of its $1.1B portfolio in Q2 2016.
  • Meag Munich Ergo opened 31 new positions and closed 95 in Q2 2016.
  • Meag Munich Ergo's portfolio value fell 43% quarter-over-quarter to $1.1B.

Based on Meag Munich Ergo's 13F filing for Q2 2016, filed 29 Jul 2016.